Instituto de Investigaciones Clínicas Tucumán
Somos un centro dedicado a la investigación clínica desde 1998. Nuestros principales objetivos son la excelencia y el compromiso con nuestros pacientes.Monteagudo 524, San Miguel de Tucumán
Select an option
I am a doctor
I am a sponsor
Specializations
Diabetes
Lupus eritematoso sistémico
Enfermedad de Chagas
Cardiología
Our team
Medical staff
Florencia Waisman
Carla Florencia Pinna
Antonella Dmayo
Maria Veronica Leonard
Eduardo Gabriel Hasbani
Maria Fernanda Bimbi Alderete
Eduardo Ezequiel Martínez
Ana Lucia Barbaglia Navarro
Lourdes DMayo
Cecilia Venturini
Verónica Bellomio
Aldo Prado
Walter Spindler
Alberto Berman
Open studies
Cardiovascular disease
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event - AZURE-Outcomes - AstraZenecaSee more
Heart failure
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure - EASi-HF - Boehringer IngelheimSee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function - BalanceD-HF - AstraZenecaSee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Obesity
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
